School of Medicine
Showing 201-300 of 1,139 Results
-
Katharine Dahl
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Kate Dahl specializes in working with children and families who are affected by medical illness. She has practiced at Stanford since 2014 and is the primary pediatric psychologist for the dialysis, kidney transplant, and liver transplant medical teams. Her work often focuses on adjustment to new diagnosis, coping with illness and treatment, and adherence to the medical regimen. She is particularly interested in the experience of adolescents with chronic medical conditions and leads groups for teens who have received kidney and liver transplants.
-
Francesco Nandkumar Dandekar
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Dandekar is the Associate Director of Sports Psychiatry and a Clinical Assistant Professor at Stanford University. After graduating summa cum laude from the University of Southern California with a B.S. in Biomedical Engineering, he earned a Regents Scholarship to complete his M.D. at UC San Diego, where he received the American Academy of Neurology’s Prize for Excellence. During his residency and fellowship at Stanford, Dr. Dandekar provided care to a variety of patients utilizing a combination of medication management, psychotherapy, and lifestyle changes (sleep, nutrition, exercise, recovery). Teamed with Clinical Professor Dr. Douglas Noordsy, he helped to incorporate psychiatric services into Stanford's sports psychology program, and continues to see elite athletes as part of the Stanford Sports Psychiatry Clinic. He also specializes in treating physicians, and sees many residents, fellows, and attendings in his private practice. In his free time, he enjoys playing tennis, chess, and guitar.
-
Beth Darnall
Professor of Anesthesiology, Perioperative and Pain Medicine (Adult Pain) and, by courtesy, of Psychiatry and Behavioral Sciences (General Psychiatry & Psychology (Adult))
Current Research and Scholarly InterestsThe Stanford Pain Relief Innovations Lab is dedicated to better characterizing and treating pain with patient-centered solutions. We specialize in the conduct of large-scale acute and chronic pain clinical trials that aim to (1) expand and scale access to behavioral medicine via digital and brief treatments; (2) reduce opioid risks via reduction for some and improved opioid access for others; (3) equip healthcare providers with brief behavioral medicine interventions to optimize health outcomes.
-
Smita Das
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioSmita Das, MD, PhD, MPH is Board Certified in Psychiatry, Addiction Psychiatry and Addiction Medicine. Dr. Das studied Chemistry and Statistics at Stanford, completed her Masters in Public Health at Dartmouth College, and then completed her MD/PhD in Community Health at the University of Illinois at Urbana Champaign. She completed psychiatry residency and was chief resident at Stanford followed by an addiction psychiatry fellowship at UCSF. She has over 2 decades of experience in research in healthcare quality and addiction. Dr. Das is chair of the APA Council on Addiction Psychiatry and has been a member for a over a decade. She has been a leader in the Northern California Psychiatric Society since 2012 and is a Past President of the APA District Branch. Prior to her position as Medical Director of Psychiatry at Lyra Health, Dr. Das was Director of Addiction Treatment Services at the Palo Alto VA. In addition to her work at Lyra, Dr. Das practices in addictions at Stanford School of Medicine where she is a Clinical Associate Professor.
-
Bruna de Freitas Dias
Postdoctoral Scholar, Psychiatry
BioI am a Brazilian physician and neuroscientist with a special interest in autoimmune neurological diseases. I graduated from Albert Einstein Medical School, Sao Paulo – Brazil in 2021. My research predominantly focuses on studying the epidemiology of autoimmune encephalitis and genetic susceptibility to the disease onset. Furthermore, I am interested in assessing the burden of the disease in those patients, socioeconomic analysis, and environmental and infectious triggers for the disease onset. At Mignot’s Lab, I am involved in IGNITE project, and I am working in the association of clinical and epidemiological data, KIR sequencing, and GWAS analysis.
My interests include general neurology, neuroimmunology, neuroscience, healthcare, and technology. -
Sallie De Golia
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. De Golia specializes in the treatment of mood and anxiety disorders with an expertise in time-limited dynamic psychotherapy. She is Section Chief of the Assessment Clinics and Director of the Evaluation Clinic. Dr. De Golia is the Residency Director of the Adult Psychiatry Residency Program where she has been involved in overall program management, educational programming, curricular development and mentorship of a residency program involving 52 residents. She is a Peer Teaching Coach and Fellow in the Stanford Teaching and Mentoring Academy, has taught regularly with the Stanford Center for Faculty Development, and is a Senior Fellow at Stanford's Center for Innovation in Global Health. She currently serves on the Executive Committee of the American Association of Directors of Psychiatry Residency Training.
-
Luis de Lecea
Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical and Translational Neurosciences Incubator)
Current Research and Scholarly InterestsMy lab uses molecular, optogenetic, anatomical and behavioral methods to identify and manipulate the neuronal circuits underlying brain arousal, with particular attention to sleep and wakefulness transitions. We are also interested in the changes that occur in neuronal circuits in conditions of hyperarousal such as stress and drug addiction.
-
Charles DeBattista
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology - Adult)
Current Research and Scholarly InterestsTreatment resistant depression.
Novel biological interventions in the treatment of mental illness.
Anti-glucocorticoid drugs in the treatment of mood disorders.
Augmentation strategies in the treatment of depression. -
Karl Deisseroth
D. H. Chen Professor, Professor of Bioengineering and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsKarl Deisseroth's laboratory created and developed optogenetics, hydrogel-tissue chemistry (beginning with CLARITY), and a broad range of enabling methods. He also has employed his technologies to discover the neural cell types and connections that cause adaptive and maladaptive behaviors.
-
Huiqiong Deng, MD, PhD
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Huiqiong Deng is a clinical assistant professor of psychiatry. In addition to a medical degree, she earned a PhD, with a major in rehabilitation science and a minor in neuroscience. Specializing in the treatment of alcohol/substance addiction, interventional and cultural psychiatry, her goal is to help each patient along the journey to achieve optimal health and quality of life.
As the co-author of more than a dozen scholarly articles, Dr. Deng’s work has appeared in Psychiatry Research, Journal of Studies on Alcohol and Drugs, American Journal on Addictions, Brain Stimulation, and other publications.
Dr. Deng has won numerous honors and awards such as the National Institute on Drug Abuse Young Investigator Travel Award, the Ruth Fox Scholarship from the American Society of Addiction Medicine, and College on the Problems of Drug Dependence Travel Award for Early Career Investigators. In addition, she was selected to attend the Annual American Psychiatry Association Research Colloquium for Junior Investigators. Since she joined faculty at Stanford, Dr. Deng has received research grant support by the Department of Psychiatry and Behavioral Sciences Innovator Grant Program. -
Ana C. DiRago, Ph.D.
Academic Staff - Hourly - CSL, Psychiatry and Behavioral Sciences
BioDr. DiRago is a bilingual (Spanish) licensed clinical psychologist who specializes in diagnostic psychological and neuropsychological evaluations of individuals across the lifespan. In her role as Adjunct Professor, she teaches and supervises fellows in the Stanford Forensic Psychiatry Fellowship Program. She is a member of the Program in Psychiatry and the Law.
-
Jasmine Dobbs-Marsh, PsyD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Jasmine Dobbs-Marsh is a licensed psychologist who specializes in the management of trauma, complex trauma, interpersonal anxiety, mood disorders, and identity-related concerns. She received her doctorate in Clinical Psychology from the PGSP-Stanford Psy.D. Consortium and her BA with Distinction in Psychology and Political Science from Stanford University. She completed her clinical internship at the UCLA Counseling and Psychological Services and her postdoctoral fellowship at Stanford University’s School of Medicine. She provides psychotherapy and clinical supervision from an intersectional lens. Dr. Dobbs-Marsh currently serves patients through the DBT, PTSD, and THRIVE Clinics at Stanford School of Medicine. Within the DBT Clinic, she provides individual DBT, DBT Skills Group, and specialized care through the DBT-Trauma program and the DBT Couple and Family Program.
-
Chunyang Dong
Postdoctoral Scholar, Psychiatry
BioChunyang Dong completed his Ph.D. studies from University of California, Davis with Dr. Lin Tian, where he specialized in protein engineering to develop genetically encoded biosensors to enable real-time imaging of neuromodulator dynamics. As part of his postdoctoral pursuits with Dr. Sergiu Pasca at Stanford University, he hopes to combine disciplines between biosensors and modeling human neurological disease using brain region-specific organoids. Despite this shift, his unwavering goal is to deepen the understanding of brain development, disease processes, and translate research to potential treatments for neurological disorders.
-
Igor D. Bandeira
Postdoctoral Scholar, Psychiatry
BioIgor D. Bandeira, M.D., Ph.D., is a physician-scientist from Salvador in Brazil, working as a Postdoctoral Research Fellow in the Department of Psychiatry and Behavioral Sciences at Stanford University. He completed his Doctor of Medicine (M.D.) at the Federal University of Bahia (Brazil), where he received the prestigious Professor Alfredo Thomé de Britto Award for outstanding graduate scientific research. Part of his medical training took place at the University of Sydney (Australia) through a Science Without Borders Scholarship. In parallel with his formal graduate training, he worked as a researcher at the university’s Brain and Mind Centre during this period. As an attending physician, Dr. Bandeira acquired further clinical experience at the Brazilian Ministry of Health. Furthermore, during the pandemic, Dr. Bandeira worked on the Brazilian frontline in the fight against Covid-19. With respect to research, he has several years’ experience applying noninvasive brain stimulation techniques in the fields of neurology and psychiatry. During his Ph.D. at the Federal University of Bahia, Dr. Bandeira has also acquired expertise in developing clinical trials to test the efficacy of rapid-acting antidepressants. His work involved using ketamine and its enantiomers (e.g., esketamine and arketamine) for treatment-resistant depression (TRD) and bipolar depression. Since he arrived at Stanford, he has built on his previous training in clinical trials by leading (A) the Wellcome LEAP multisite accelerated intermittent theta burst stimulation (Stanford Neuromodulation Therapy) trial for anhedonic depression and co-leading (B) a trial testing the efficacy and safety of buprenorphine in sustaining the anti-suicide properties of ketamine.
-
Shaul Druckmann
Associate Professor of Neurobiology, of Psychiatry and Behavioral Sciences and, by courtesy, of Electrical Engineering
Current Research and Scholarly InterestsOur research goal is to understand how dynamics in neuronal circuits relate and constrain the representation of information and computations upon it. We adopt three synergistic strategies: First, we analyze neural circuit population recordings to better understand the relation between neural dynamics and behavior, Second, we theoretically explore the types of dynamics that could be associated with particular network computations. Third, we analyze the structural properties of neural circuits.
-
Tianwei Du
Postdoctoral Scholar, Psychiatry
BioDr. Du's clinical interests focus on providing evidence-based treatment to individuals with emotion dysregulation, interpersonal difficulties, and/or complex trauma. She is also passionate about addressing diversity factors in clinical work. Dr. Du provides services in the Dialectical Behavior Therapy (DBT) Adult Program, the Anxiety and Depression Adult Psychological Treatment (ADAPT) Clinic, and the Stanford Mental Health for Asians Research and Treatment (SMHART) Clinic. Dr. Du is a bilingual clinician speaking English and Mandarin.
Dr. Du's research focuses on exploring the roles of interpersonal processes and personality in psychopathology, and she has published widely on this topic. Dr. Du also participated in a variety of clinical trials to help develop and improve evidence-based interventions for individuals with complex clinical presentations and populations with limited access to mental health care. -
Laramie Duncan
Assistant Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)
Current Research and Scholarly InterestsWe study genetic and environmental effects on mental health. Much of our work is computational and it relies upon genetic data, collected from millions of individuals, from around the world. We use genetic approaches because the overall goal of the lab is to discover fundamental information about psychiatric disorders, and ultimately to build more rational approaches to classification, prevention, and treatment.
-
Timothy Durazzo
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsThe mission of the Durazzo BRASS lab is to better understand how the interplay between biomedical, psychological and social factors influence treatment outcome in Veterans and civilians seeking treatment for alcohol and substance use disorders. To accomplish this mission, our multidisciplinary team integrates information from advanced neuroimaging, neurocognitive assessment, psychodiagnostic and genotyping methods to identify the biopsychosocial factors associated with relapse and sustained sobriety. Veteran's Administration and Stanford funded Clinical trials are currently being conducted by the BRASS lab that evaluate repetitive transcranial magnetic stimulation techniques as novel complementary treatments to reduce the high rate of relapse experienced by individuals with alcohol and substance abuse disorders. The ultimate goal of our multidisciplinary research program is to promote the development of more effective biomedical and behavioral treatments for alcohol and substance use disorders through consideration of the brain biology, psychology and social circumstances of each individual.
-
David Eagleman
Adjunct Professor, Psych/Public Mental Health & Population Sciences
BioDavid Eagleman is a neuroscientist, bestselling author, and Guggenheim Fellow. Dr. Eagleman’s areas of research include sensory substitution, time perception, vision, and synesthesia. He also studies the intersection of neuroscience with the legal system, and in that capacity he directs the non-profit Center for Science and Law. Eagleman is the writer and presenter of The Brain, an Emmy-nominated television series on PBS and BBC. He is the author of 8 books, including Livewired, The Runaway Species, The Brain, Incognito, and Wednesday is Indigo Blue. He is also the author of a widely adopted textbook on cognitive neuroscience, Brain and Behavior. His internationally bestselling book of literary fiction, SUM, has been translated into 32 languages, turned into two operas, and named a Best Book of the Year by Barnes and Noble. Dr. Eagleman has been a TED speaker, a guest on the Colbert Report, and profiled in the New Yorker magazine. He has launched several neuroscience companies from his research, including Neosensory and BrainCheck.
-
Matthew L. Edwards
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioMatthew Edwards is an assistant professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. In this role, Matthew also serves as the assistant director of residency training for the general adult psychiatry residency program. His clinical interests are in community and forensic psychiatry and his research interests lie at the intersection of medical history, ethics, and public policy.
Dr. Edwards graduated from Princeton University in 2010 with a degree in Sociology, magna cum laude, and received a graduate certificate in public health from the University of Texas School of Public Health in 2012. He received his MD, summa cum laude, with honors in research from the University of Texas Medical Branch School of Medicine in 2017. He completed his residency training in adult psychiatry at Stanford University School of Medicine in 2021 and his fellowship in forensic psychiatry at Emory University School of Medicine in 2022. He was a Pearce Fellow in the History of Medicine at the Clendening Library of the University of Kansas Medical Center in 2015.
His clinical interests are in community psychiatry and forensic psychiatry. At Stanford, Dr. Edwards treats patients in the division of adult psychiatry and the centerspace clinic. This recovery-oriented clinic provides culturally-contextualized and trauma-informed care for people with marginalized, multiple, and intersecting identities. He teaches the history of psychiatry to general psychiatry residents and forensic psychiatry fellows. Dr. Edwards regularly speaks about race, trauma, structural inequality, and the history of medicine at conferences and invited lectures. -
Katherine Eisen
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Eisen is a Clinical Associate Professor and CA Licensed Clinical Psychologist in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She works with the INSPIRE clinic at Stanford and is the Inpatient Director of Psychological Services for the acute inpatient psychiatric units at Stanford Hospital. Her research and clinical interest center on therapeutic interventions that support recovery for individuals living with serious mental illness, in particular for individuals experiencing psychosis. Dr. Eisen received her bachelor’s degree from Cornell University, and her PhD from the University of Connecticut, and completed postdoctoral training at Stanford University. She is trained in CBT for psychosis (CBTp) and provides training and consultation in CBTp and CBTp informed skills to community-based clinicians, graduate students, medical students and residents, to support the use of recovery-oriented psychosocial interventions with individuals experiencing psychosis.
-
Cassondra Eng
Postdoctoral Scholar, Psychiatry
BioDr. Eng is a NIH funded T32 Sports Neuroscience Postdoctoral Scholar in the Center for Interdisciplinary Brain Sciences Research. She investigates optimizing immersive interventions that promote neurological, cognitive, and physical health outcomes from a multimethodological approach. Dr. Eng's research program focuses on attentional processes in varying technologically-enhanced contexts, with a focus on the neurophysiological mechanisms that produce differential outcomes using portable functional near-infrared spectroscopy (fNIRS), a modern neuroimaging technique ideal for children and neurodiverse populations because it is noninvasive and permits mobility in naturalistic settings. She specializes in utilizing behavioral, neurophysiological, and statistical methods across development: standard task-based and clinical norm-referenced assessments of attention, quantitative and qualitative assessments of children’s behavior and learning in ecological contexts; eye tracking, fNIRS, EEG, cardiovascular changes related to performance and stress; mixed effects modeling, multivariate analysis, educational data mining, and modern longitudinal data analysis.
Dr. Eng earned her Ph.D. from Carnegie Mellon University in Developmental Psychology and Cognitive Neuroscience and Program for Interdisciplinary Education Research Certification through an Institute of Education Sciences-funded Predoctoral Fellowship after completing an NIH funded Post-Baccalaureate Research Education Program at Virginia Tech. She advocates for educational neuroscience: the field bridging cognitive science, psychology, educational technology, human-computer interaction, computer science and related disciplines to understand the optimal learning contexts that support brain development and cognitive skills crucial for overall wellbeing and success. -
Neir Eshel, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator)
BioDr. Eshel (he/him/his) is a tenure-track Assistant Professor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine.
His clinical focus is the full-spectrum mental health care of sexual and gender minorities, with particular interest in depression, anxiety, and the complex effects of trauma in this population. He works in collaboration with other primary care and mental health providers at the Stanford LGBTQ+ program.
His research interests (www.staarlab.com) include the use of optogenetic, electrophysiological, neuroimaging, and behavioral approaches to probe the neural circuits of reward processing, decision making, and social behavior. He has won multi-year grants from the National Institutes of Health, Burroughs-Wellcome Fund, Brain and Behavior Research Foundation, and Simons Foundation to further his research.
Dr. Eshel has published articles on dopamine and motivation, the neuroscience of irritability, LGBTQ health, reward and punishment processing in depression, behavioral predictors of substance use among adolescents, and the mechanism of transcranial magnetic stimulation. His work has appeared in Nature, Science, Neuron, Nature Neuroscience, Annual Review of Neuroscience, JAMA, JAMA Psychiatry, Neuropsychopharmacology, Proceedings of the National Academy of Sciences, and Journal of Neuroscience. He is a co-inventor on a patent pending for a new class of drugs for addiction, and also the author of the book Learning: The Science Inside, a publication of the American Association for the Advancement of Science.
He has delivered presentations on the neural circuits of motivated behavior, anger expression in patients with PTSD, how dopamine facilitates learning, and LGBTQ-related topics at departmental seminars in London, Zurich, and Tel Aviv, and at the meetings of the American College of Neuropsychopharmacology, Society of Biological Psychiatry, and Association of American Medical Colleges, among others. He is also an associate editor of the Journal of Gay and Lesbian Mental Health, and an ad-hoc reviewer for numerous publications including Nature, Science, JAMA Psychiatry, Biological Psychiatry, and Current Biology.
Dr. Eshel has won honors for his scholarship and advocacy, including the Marshall Scholarship, the Outstanding Resident Award from the National Institute of Mental Health, the Science and SciLifeLab Grand Prize for Young Scientists, the Freedman Award (honorable mention) from the Brain and Behavior Research Foundation, the Polymath Award from Stanford's psychiatry department, and the National LGBT Health Achievement Award.
He is a member of the American Psychiatric Association, American College of Neuropsychopharmacology, Society of Biological Psychiatry, Association of Gay & Lesbian Psychiatrists, Society for Neuroscience, and other professional associations. He is also an advocate for LGBTQ rights, recently serving as the chair of Stanford's LGBTQ+ Benefits Advocacy Committee.
Prior to Stanford, Dr. Eshel trained and conducted research at the National Institutes of Health, Princeton University, the World Health Organization, University College London, and Harvard University. -
Flint Espil
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Flint Espil researches the etiology and treatment of tic disorders (including Tourette’s), Obsessive-Compulsive Disorder, and body-focused repetitive behaviors. He is interested in how psychosocial factors, the environment, and underlying brain circuitry influence treatment outcomes among individuals seeking treatment. He is also exploring ways to adapt and implement evidence-based mental health approaches in community settings. He is currently collaborating with community-based organizations in East Palo Alto to improve access to care for youth in school settings.
-
Stephanie Allen Evans
Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioResume visible at http://bit.ly/EvansResume
This link needs to be copied and pasted into your browser to view. -
Audrey Evers
Casual - Non-Exempt, Psych/General Psychiatry and Psychology (Adult)
Current Role at StanfordClinical Psychology Doctoral Student, PGSP-Stanford PsyD Consortium
Clinical Research Coordinator, Depression Research Clinic -
Afik Faerman
Postdoctoral Scholar, Psychiatry
BioAfik Faerman, Ph.D., is a clinical neuropsychology postdoctoral scholar and an NIMH T32 fellow at the Stanford Brain Stimulation Lab (PI: Nolan Williams) and the Center for Mind, Body, and Health (PI: David Spiegel). He completed his clinical training at the University of California, San Francisco (UCSF) and Baylor College of Medicine and earned his Ph.D. in clinical psychology with emphasis in neuropsychology from Palo Alto University. His research centers on the modulation of consciousness and its clinical relevance, focusing on psychedelics, brain stimulation, hypnosis, sleep, and performance. His work has been acknowledged and supported by the American Psychological Association (APA), the Society for Clinical and Experimental Hypnosis (SCEH), the American Society for Clinical Hypnosis (ASCH), the Sleep Research Society (SRS), and more. He is the president-elect of the APA Division 30 (Psychological Hypnosis) and is the past chair of the Student Committee at the Association for the Scientific Study of Consciousness (ASSC).
-
William O Faustman
Clinical Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioDr. Faustman received his doctorate in clinical psychology from the University of Mississippi and completed his internship at the VA Palo Alto Health Care System. He has an active interest in training, administration, forensic practice, and clinical care in inpatient psychiatry. His research interests have focused on severe mental illness with an emphasis in areas such as cognition and clinical assessment.. He serves as a member of the Stanford IRB and coordinates the American Psychological Association accredited postdoctoral fellowship program at the VA Palo Alto. He holds Chartered Psychologist status with the British Psychological Society,
-
Carl Feinstein
Professor of Psychiatry and Behavioral Sciences at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsAutism and Asperger's Disorder.
Genetically-based neurodevelopmental disorder, including Velocardiofacial Syndrome, Smith-Magenis Syndrome, Williams Syndrome, and Fragile X Syndrome.
Intellectual Disability (mental retardation) and psychiatric disorders.
Developmental Language Disorder and Learning Disabilities.
Sensory impairment in children, including visual and hearing impairment.
Psychiatric aspects of medical illness and disability in children. -
Howard H Fenn MD
Clinical Associate Professor (Affiliated), Psych/Public Mental Health & Population Sciences
BioCurrent CV available on request to
hhfenn@aol.com
CLINICAL:
Inpatient psychiatry attending at VA HCS Palo Alto for over 30 years.
Medical Director, Geriatric Psychiatry unit, VA HCSC Palo Alto/Menlo Park for 10 years
Outpatient psychiatrist at Palo Alto Medical foundation/Sutter for 15 years
CURRENT PUBLICATIONS:
Lead Editor, Inpatient Geriatric Psychiatry, Springer, 2019
LEGAL/FORENSIC:
Consultation practice on legal issues and court testimony for >40 years
Expert consultant/witness for Coleman vs. California Department of Corrections for 4 years
Qualified Medical Examiner (QME) for Division of Worker's Compensation for 15 years
Compensation and Pension Unit, VA HCS Palo Alto for 5 years
SEMINAR LEADER:
Psychiatric Issues in Cognitive Impairment -- Stanford/VA Alzheimer's Center (SVAAC)
Legal Aspects of Geriatric Psychiatry (Stanford/VA Geriatric Psychiatry Fellowship
Didactic topics on inpatient psychiatry rotation for Stanford Geriatric Psychiatry fellows
EDUCATIONAL/ADMINISTRATIVE:
Program Director, Stanford/VA Geriatric Psychiatry Fellowship, 3 years
Site Director, Inpatient Psychiatry Rotation/Geriatric Medicine Fellowship --6 years
SCHOLARSHIP:
Lead Editor of textbook, Inpatient Geriatric Psychiatry, published by Springer in 2019.
Slide presentations published by the American Society of Clinical Pharmacology (ASCP), editor Ira Glick, MD, entitled:
--Pharmacological Treatment of PTSD
--Behavioral and Psychological symptoms of Dementia
Chapters, review articles on topics of Medication management for Major Neurocognitive Disorder with Behavioral Disturbance
Chapter in Inpatient Geriatric Psychiatry, in On-Call Geriatric Psychiatry (2016), Springer.
. -
Emily Ferguson, PhD
Postdoctoral Scholar, Psychiatry
BioEmily Ferguson, Ph.D., is a postdoctoral academic researcher and clinician within Stanford University’s Autism and Developmental Disorders Research Program (https://med.stanford.edu/autism.html) within the Department of Psychiatry and Behavioral Sciences. She earned her doctoral degree in Clinical Psychology from the University of California Santa Barbara and completed her clinical internship at the University of California Los Angeles. Dr. Ferguson's research focuses on advancing understanding of mechanisms of challenging behaviors in autistic youth and adults to inform treatment development. Her work takes a comprehensive perspective, integrating methods from implementation science to improve the accessibility and quality of clinical care for underserved autistic populations, especially those with higher support needs (or "profound autism"). She is also interested in developing methods to improve self-regulation in individuals with profound autism to effectively manage self-injurious behaviors and aggression. Dr. Ferguson is currently supporting research in the Preschool Autism Lab (https://med.stanford.edu/autismcenter/pre-school-autism-lab-program.html), and exploring profiles of challenging behaviors with the Program for Psychometrics and Measurement-Based Care (https://med.stanford.edu/sppmc.html) in a diverse range of autistic and non-autistic youth to inform treatment approaches.
-
Adina S. Fischer, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
On Leave from 10/10/2022 To 10/09/2024BioDr. Fischer’s research focuses on characterizing risk and resilience factors in depression. She has been awarded an NIH Career Development Award (K23) and Klingenstein Foundation Fellowship in Adolescent Depression to build her program of clinical and translational research at Stanford. Dr. Fischer's program of clinical care focused on the delivery and teaching of evidence-based clinical interventions that enhance resilience, with a focus on addressing the unique stressors encountered in academia and academic medicine that may contribute to risk and resilience in mood and anxiety disorders.
Dr. Fischer’s translational program of research focuses on:
(1) Improving our understanding of protective biomarkers of resilience to depression
(2) Characterizing the effects of cannabis on neurobiological function and depressive symptoms
(3) Developing neurobiologically-guided interventions for depressive disorders, particularly those that co-occur with cannabis and other substance use
Dr. Fischer earned her BSc at the Massachusetts Institute of Technology in Brain and Cognitive Sciences, where she conducted research in the Early Childhood Cognition Laboratory. She then completed the MD/PhD Program at Dartmouth, where she obtained her PhD in in Neuroscience. Dr. Fischer’s doctoral research focused on characterizing the acute effects of cannabis in patients with schizophrenia and co-occurring cannabis use disorder. She then completed the Stanford Psychiatry Residency Training Program as a member of the Research Track, and an NIH funded T-32 postdoctoral research fellowship within the Department of Psychiatry and Behavioral Sciences. -
Caroline Fleck
Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences
BioDr. Caroline Fleck received her doctorate in Psychology & Neuroscience from Duke University, and went on to specialize in cognitive behavioral therapies including Exposure and Response Prevention, Dialectical Behavior Therapy, Parent Management Training, Gottman Method Couples Therapy, and Behavioral Activation. She is the founder and clinical director of Luma - a network of evidence-based clinicians in private practice. Dr. Fleck is also a trainer, educator, and public speaker on the topics of evidence-based approaches in psychology, mindfulness, and the use of technology in mental health care. Her lectures and courses at Stanford focus on training residents, post-docs, and faculty in Dialectical Behavior Therapy, and risk management.
More information can be found on her website: https://www.drcarolinefleck.com/ -
Lara Foland-Ross
Senior Research Scholar, Psychiatry and Behavioral Sciences - Interdisciplinary Brain Sciences
BioI am a neuroscientist in the Division of Interdisciplinary Brain Sciences in the Department of Psychiatry and Behavioral Sciences at Stanford University. I use a variety of imaging modalities -including EEG, fNIRS and fMRI- to examine the neurobiology of mood and cognition in adolescents. The primary aim of my work is to understand how neurodevelopment is altered in adolescents with clinical and metabolic disorders, and the neuropsychiatric consequences of these alterations. Current projects include the study of adolescents with disordered puberty, type 1 diabetes, and Fragile-X syndrome. Moreover, I'm examining the neural basis of imposter syndrome and stereotype threat in women. I deeply value the process of acting on curiosity, learning from challenges, and applying creative solutions to both highlight and address gaps in our understanding of the brain and cognition.
-
Sai Folmsbee, MD, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsMy current research interest is the intersection of psychiatry and neuroimmunology. I am currently collaborating with Stanford Neuroimmunology in a retrospective analysis of patient data to determine the relationship between psychaitric medications and clinical outcomes in hospitalized patients with mutliple sclerosis, autoimmune encephalitis, and neuromyelitis optica.
-
Judith Ford
Professor (Research) of Psychiatry and Behavioral Sciences, Emeritus
Current Research and Scholarly InterestsWe are using functional brain imaging methods (electrophysiology and magnetic resonance imaging) to study symptoms of schizophrenia such as auditory hallucinations, self-monitoring failures, emotional blunting, and cognitive deficits.